NBC Connecticut

FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions

Baillies, a human resources specialist based in Milwaukee, Wisconsin, has been attempting to lose weight and dealing with chronic autoimmune issues for years, so she turned to a cheaper alternative: a ...
Seeking Alpha

New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect

With all doses of FDA-approved Wegovy ® fully available nationwide, it is illegal under US compounding laws to make or sell knockoff "semaglutide" drugs, with rare exceptions New, one-time $199 ...
Seeking Alpha

Zoetis: High-Quality Compounder For Patient Long-Term Dividend Growth Investors

Zoetis is a US-based company involved in the discovery, development, manufacture, and marketing of animal medicines and vaccines. ZTS has increased its dividend for 13 consecutive years. This streak ...
AOL

Americans scramble as weight-loss drug discounts fall short, copies face crackdown

(Reuters) -After years of easily available, cheap copies of Eli Lilly's and Novo Nordisk's highly effective weight-loss drugs, some U.S. patients say they are unwilling to pay more and are pursuing ...
Psychology TodayOpinion

The Dangerous Allure of Compounded GLP-1 Drugs

Compounded GLP-1 medications help fill a necessary gap, but can have significant safety issues. Compounded GLP-1 medications ...
MarketWatch

Strive Compounding Pharmacy Files Landmark Antitrust Lawsuit Against Eli Lilly and Novo Nordisk

The MarketWatch News Department was not involved in the creation of this content. Lawsuit alleges anti-competitive conduct designed to suppress lawful compounding pharmaceuticals and limit patient ...